There is no peptide that builds muscle the way steroids do. The compounds people mean when they search “muscle peptides” mostly nudge one system — the growth-hormone and IGF-1 axis — or help the body recover from training, rather than directly forcing muscle to grow.
The honest state of the evidence: most of it is preclinical or comes from people who were growth-hormone deficient or ill, not healthy lifters. That does not make these compounds uninteresting to researchers — it means the hype runs well ahead of the data. Here is what each one is actually studied for, ranked by how solid the evidence is.
The honest starting point
“Muscle peptides” is a marketing bucket, not a pharmacology category. Almost everything in it works through one of three routes: raising your own growth hormone (the GH secretagogues), acting like IGF-1 (the hormone GH works through), or helping tissue recover so you can train harder (the repair peptides). None of them is an anabolic steroid, and the difference matters — we cover it in peptides vs steroids vs HGH.
Keep one fact in mind throughout: raising GH and IGF-1 is not the same as building muscle. In healthy adults, boosting GH reliably changes body composition markers and water balance far more than it reliably adds contractile muscle or strength. That gap between “moves a hormone” and “adds usable muscle” is where most of the honest debate lives.
Raising growth hormone is easy. Proving it adds real, usable muscle in a healthy trained adult is the part the research keeps struggling with.The distinction the supplement ads leave out
GH secretagogues
These are the peptides that prompt your pituitary to release more of your own growth hormone. They come in two flavours that are often combined in research: GHRH analogs and ghrelin-mimetic “GH-releasing peptides.”
- Ipamorelin — a selective ghrelin-mimetic studied for a clean GH pulse with relatively little effect on cortisol or appetite. See the ipamorelin research guide.
- CJC-1295 — a long-acting GHRH analog, frequently paired with ipamorelin in research so that one raises the baseline and the other adds a pulse. See CJC-1295 and ipamorelin.
- Tesamorelin — the most clinically validated GHRH analog, approved as a drug (Egrifta) for visceral fat in HIV patients, where it reliably raised IGF-1. Its muscle story in healthy people is far less established. See tesamorelin and belly fat.
The comparator everyone brings up is MK-677 (ibutamoren), an oral ghrelin mimetic. In a well-known 2008 trial in older adults it increased GH, IGF-1 and lean body mass — but the lean-mass gain was largely attributed to fluid, not clearly to contractile muscle or strength. MK-677 is not part of the TrueLabs catalogue; it is useful here only because it is the best-studied example of what GH secretagogues actually do and do not do.
IGF-1 and IGF1-LR3
Growth hormone does much of its work through insulin-like growth factor 1 (IGF-1), which acts on muscle satellite cells and protein synthesis. IGF1-LR3 is a modified, long-acting version studied in cell and animal models for exactly these muscle-growth pathways. It is a staple of laboratory hypertrophy research — and a good example of the evidence gap, because impressive results in a dish or a rodent have not been matched by controlled human muscle-building trials. For the distinction between native IGF-1 and the LR3 analog, see IGF-1 vs IGF-1 LR3.
Repair peptides that support training
A different and genuinely popular group does not target muscle growth at all — it targets recovery. BPC-157 and TB-500 are studied, mostly in animals, for tendon, ligament and soft-tissue repair and angiogenesis. The logic for lifters is indirect: an athlete who recovers from niggles trains more consistently, and consistency builds muscle. That is a reasonable research rationale, not proof of a muscle-building effect. Compare them in BPC-157 vs TB-500.
MOTS-c and the metabolic angle
MOTS-c is a mitochondrial-derived peptide studied as a kind of “exercise mimetic” — in animal work it influenced metabolic flexibility and endurance capacity. That is about energy and metabolism rather than hypertrophy, but it is why it shows up in performance-research conversations. See what is MOTS-c.
The honest evidence table
| Compound | Class | Studied for | Human muscle evidence |
|---|---|---|---|
| Tesamorelin | GHRH analog | Visceral fat, raising IGF-1 | Strongest clinical data of the group, but for fat/IGF-1, not hypertrophy |
| Ipamorelin | Ghrelin mimetic | Selective GH release | Mostly preclinical; little healthy-adult muscle data |
| CJC-1295 | GHRH analog | Sustained GH/IGF-1 elevation | Mostly preclinical |
| IGF1-LR3 | IGF-1 analog | Satellite cells, protein synthesis | Cell/animal models; no controlled human hypertrophy trials |
| BPC-157 / TB-500 | Repair peptides | Tendon, ligament, soft-tissue repair | Mostly animal; recovery rationale, not muscle growth |
| MOTS-c | Mitochondrial peptide | Metabolism, endurance (exercise mimetic) | Animal; metabolic, not hypertrophy |
What the evidence does not show
Three honest limits worth stating plainly:
- No controlled trials show these build muscle in healthy trained adults. The strongest human data (tesamorelin, MK-677) is about IGF-1 and body composition in specific patient groups, and the lean-mass changes are heavily fluid-driven.
- Peptides are not steroids or HGH. They nudge your own hormones within a physiological range; they do not replicate supraphysiologic anabolic effects. That is a feature for researchers, not a loophole.
- Repair is not growth. BPC-157 and TB-500 may support recovery research, but recovering faster is not the same as a direct hypertrophic signal.
None of these compounds is an approved muscle-building drug, and several (such as GH secretagogues) are prohibited in sport under WADA. TrueLabs compounds are sold for in vitro and laboratory research only, not for human performance use. This article is research background, not advice or a protocol — there is no dosing guidance here.
Muscle-peptide myths
“Myth: Peptides build muscle like steroids.”
They do not. They work on your own GH/IGF-1 axis within physiological limits, a fundamentally different and milder mechanism.
“Myth: Raising GH means more muscle.”
Raising GH reliably shifts body-composition markers and fluid, but has not reliably added contractile muscle or strength in healthy adults.
“Myth: IGF1-LR3’s lab results prove it builds muscle in people.”
Cell and animal results have not been confirmed by controlled human hypertrophy trials. The gap is large.
“Myth: BPC-157 is a muscle-growth peptide.”
It is studied for tissue repair, mostly in animals. The muscle link is an indirect recovery rationale, not a growth effect.
For researchers
If your work is in the GH/IGF-1 axis or tissue-repair models, TrueLabs supplies Ipamorelin from $40, CJC-1295 from $31, Tesamorelin from $37, IGF1-LR3 from $15, BPC-157 from $22, TB-500 from $55 and MOTS-C from $55, in CAD for in vitro and laboratory research only. Before ordering, see how to read a peptide COA and the COA library.
FAQ
Tap a question to reveal the answer.
What is the best peptide for muscle growth?
There is no proven best, because none is proven to build muscle in healthy trained adults. The most clinically validated GH-axis peptide is tesamorelin, but its data is about IGF-1 and fat, not hypertrophy. Treat any “best muscle peptide” claim with skepticism.
Do growth hormone peptides actually build muscle?
They raise your own GH and IGF-1, which shifts body-composition markers, but studies have not reliably shown added contractile muscle or strength in healthy adults. Much of the lean-mass change is fluid.
Are peptides the same as steroids?
No. Peptides nudge your own hormones within a physiological range; anabolic steroids and HGH act far more powerfully and differently. See our peptides vs steroids vs HGH guide.
What does IGF1-LR3 do?
It is a long-acting IGF-1 analog studied in cell and animal models for satellite-cell activity and protein synthesis. Controlled human muscle-building trials are lacking.
Can BPC-157 and TB-500 help muscle?
They are studied mainly for tendon and soft-tissue repair in animals. The benefit to lifters would be indirect — better recovery and training consistency — not direct muscle growth.
What is MK-677 and is it sold here?
MK-677 (ibutamoren) is an oral ghrelin mimetic that raised GH, IGF-1 and lean mass in a 2008 trial, though the lean gain was largely fluid. It is not in the TrueLabs catalogue; it is referenced only as the best-studied example.
Are these legal to use for building muscle?
They are sold for laboratory research, not human performance use, and several are banned in sport under WADA. Injectable peptides are regulated as prescription drugs in Canada.
Will any peptide replace training and protein?
No. Nothing here substitutes for resistance training and adequate protein, which remain the only reliably proven way to build muscle.
Related reading
- Peptides vs steroids vs HGH
- CJC-1295 vs tesamorelin vs ipamorelin
- IGF-1 vs IGF-1 LR3
- BPC-157 vs TB-500
- Tesamorelin and belly fat
References
- Falutz J, et al. Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV. N Engl J Med. 2007;357:2359-2370. NEJM
- Nass R, et al. Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults. Ann Intern Med. 2008;149(9):601-611.
- Examine. Ibutamoren (MK-677): evidence on muscle and bone. Examine
- Health Canada. Advisory: unauthorized injectable peptide products, 2025.
This article summarizes published research and regulatory information for information only and is not medical advice. TrueLabs research compounds are sold for in vitro and laboratory research use only and are not intended for human or veterinary use.